Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of Antiadipositum X 112 T (cathine hydrochloride) in overweight and obese patients
DRKS00000543Phase 2Completed
- Sponsor
- RIEMSER
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cathine in obesity and Overweight (4 arms), sponsored by RIEMSER. Started Sep 2010; status: completed.
02
Drugs
cathine
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on DRKS00000543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000543.